Fujian Fukang Pharmaceutical Co. Ltd.

Main objective: To evaluate the relative bioavailability and bioequivalence of piracetam tablets produced by Fujian Fukang Pharmaceutical Co., Ltd. as the test preparation and piracetam tablets produced by UCB Pharma S.A. as the reference preparation in humans.

Healthy volunteers were selected to conduct single and multiple pharmacokinetic trials of cefuroxime sodium for injection in humans. By conducting low-, medium- and high-dose single and medium-dose multiple pharmacokinetic trials, the time-dependent blood concentration of cefuroxime sodium was determined, its main pharmacokinetic parameters were estimated, and the absorption, distribution and elimination patterns of cefuroxime sodium for injection in healthy humans were understood, providing an experimental basis for formulating subsequent test plans and a basis for clinical drug dosage.